BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its registered common stock to Azimuth Opportunity, Ltd. over an 18-month period. NPS is not obligated to utilize the facility and remains free to enter into other financing transactions (other than another committed equity financing facility). NPS did not pay a commitment fee or issue any warrants to secure this facility.
